ANDRX CORP /DE/
10-Q, EX-27.1, 2000-11-20
PHARMACEUTICAL PREPARATIONS
Previous: ANDRX CORP /DE/, 10-Q, 2000-11-20
Next: BUSINESS BANCORP /CA/, 10QSB, 2000-11-20



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S UNAUDITED FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH UNAUDITED FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                     130,549,000
<SECURITIES>                               212,178,000
<RECEIVABLES>                               82,815,000
<ALLOWANCES>                                (6,166,000)
<INVENTORY>                                 82,476,000
<CURRENT-ASSETS>                           531,074,000
<PP&E>                                      84,222,000
<DEPRECIATION>                             (17,208,000)
<TOTAL-ASSETS>                             626,568,000
<CURRENT-LIABILITIES>                       84,425,000
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        84,000
<OTHER-SE>                                 542,059,000
<TOTAL-LIABILITY-AND-EQUITY>               626,568,000
<SALES>                                    364,862,000
<TOTAL-REVENUES>                           376,305,000
<CGS>                                      214,299,000
<TOTAL-COSTS>                              313,898,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             735,000
<INCOME-PRETAX>                             74,632,000
<INCOME-TAX>                                30,762,000
<INCOME-CONTINUING>                         43,870,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                43,870,000
<EPS-BASIC>                                       0.75
<EPS-DILUTED>                                     0.72



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission